Crunching the numbers for SOLS... Refresh in a moment for the full analysis.
Solstice Advanced Materials Inc. (SOLS)
Healthcare
mixed
$81.96
Updated: 2026-04-12
54
TradeApes Score
hold
Financial Strength
50
Mixed
Operating Trend
50
Mixed
Valuation
50
Mixed
Capital Allocation
55
Mixed
Risk
80
Strong
Key Findings
+
Low stock compensation — SBC below 3% of revenue
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.